FDA Approves Polypill Widaplik for Hypertension
Physician's Weekly
JUNE 11, 2025
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. The most common adverse event reported in patients treated with Widaplik was symptomatic low blood pressure. All rights reserved.
52 
Let's personalize your content